Organigram Holdings (OGI) Q3 Revenues Rises 31%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Organigram Reports Third Quarter Fiscal 2021 Results
July 13, 2021 6:00 AM EDTGrew gross revenue 51% sequentially to $29.1 million in Q3 2021 from Q2 2021 and 31% from the same prior year period Grew net revenue 39% sequentially to $20.3 million in Q3 2021 from Q2 2021 and 13% from the same prior year period Grew adult-use recreational net revenue 40% sequentially to $16.8 million in Q3 2021 from Q2 2021 and 10% from the same prior year period Launched 84 new stock-keeping units (SKUs) since July 2020 as part of the Companys product portfolio revitalization including two new high potency strains under the higher margin Edison brand in Q3 2021; up to 20 more new SKUs... More



